Trader’s Watch List: ExamWorks, JAKKS Pacific, Inc
Shares of ExamWorks (NYSE: EXAM) jumped to a new all-time high Wednesday, after the provider of independent medical examinations late Tuesday reported a narrowed Q4 net loss that was smaller than expected while revenue topped Street estimates and the company forecast Q1 and 2014 revenue above analysts’ expectations. EXAM was up 17% at $35.76 recently, after hitting the fresh record at $36.85. The company posted … Continue reading Trader’s Watch List: ExamWorks, JAKKS Pacific, Inc